sting inhibitor h-151 Search Results


sting inhibitor h151  (MedChemExpress)
99
MedChemExpress sting inhibitor h151
Sting Inhibitor H151, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sting+inhibitor+h-151/H-151/10__29261_slash_pakvetj_slash_2026__026-63-11-15
Average 99 stars, based on 1 article reviews
sting inhibitor h151 - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
sting inhibitor h  (Selleck Chemicals)
94
Selleck Chemicals sting inhibitor h
Sting Inhibitor H, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sting+inhibitor+h-151/H-151/pmc11722101-466-0-6
Average 94 stars, based on 1 article reviews
sting inhibitor h - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
sting inhibitor h151  (Tocris)
94
Tocris sting inhibitor h151
(A) Representative immunoblots for <t>STING,</t> P-IκBα, IκBα, P-NF-κB p65, NF-κB p65, GATA3, P- STAT6, STAT6 and β-actin from CTRL and TKO CD4 + T cells following DMSO or <t>H151</t> (500 nM) incubation for 48 hours. (B) Protein quantitation and ratio of STING/β-actin, P-IKBα/IKBα, P-NF-kB P65/NF-kB P65, GATA3/β-actin and P-STAT6/STAT6 by densitometry analysis (n=6-7 per group). (C) IL-4, IL-5 and IL-13 cytokine release in activated CD4 + T cells treated with either DMSO or H151 (500nM) (n=6-7 per group). (D) Representative immunoblots for STING, P-IκBα, IκBα, P-NF-κB p65, NF-kB p65, GATA3 and β-actin from CTRL and TKO CD4 + T cells incubated with negative control (N.C.) or with STING siRNA. (E) Protein quantitation and ratio of STING/β-actin, P-IκBα/IκBα, P-NF-κB P65/NF-κB P65 and GATA3/β-actin by densitometry analysis (n=6 per group). (F) IL-4, IL-5 and IL-13 cytokine release in activated CD4 + T cells incubated with either N.C. or STING siRNA (n=9-18 per group). (G) Schematic representation of proposed mechanistic pathway. Values represent mean ± SEM. *p<0.05, **p<0.01, ***p<0.001 vs control mice by two-way ANOVA followed by the Tukey’s post hoc test or unpaired two-tailed student-t-test.
Sting Inhibitor H151, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sting+inhibitor+h-151/H+151/bio_rxiv__2024__03__21__586144-64-21-26
Average 94 stars, based on 1 article reviews
sting inhibitor h151 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
sting inhibitor h 151  (Tocris)
94
Tocris sting inhibitor h 151
(A) Representative immunoblots for <t>STING,</t> P-IκBα, IκBα, P-NF-κB p65, NF-κB p65, GATA3, P- STAT6, STAT6 and β-actin from CTRL and TKO CD4 + T cells following DMSO or <t>H151</t> (500 nM) incubation for 48 hours. (B) Protein quantitation and ratio of STING/β-actin, P-IKBα/IKBα, P-NF-kB P65/NF-kB P65, GATA3/β-actin and P-STAT6/STAT6 by densitometry analysis (n=6-7 per group). (C) IL-4, IL-5 and IL-13 cytokine release in activated CD4 + T cells treated with either DMSO or H151 (500nM) (n=6-7 per group). (D) Representative immunoblots for STING, P-IκBα, IκBα, P-NF-κB p65, NF-kB p65, GATA3 and β-actin from CTRL and TKO CD4 + T cells incubated with negative control (N.C.) or with STING siRNA. (E) Protein quantitation and ratio of STING/β-actin, P-IκBα/IκBα, P-NF-κB P65/NF-κB P65 and GATA3/β-actin by densitometry analysis (n=6 per group). (F) IL-4, IL-5 and IL-13 cytokine release in activated CD4 + T cells incubated with either N.C. or STING siRNA (n=9-18 per group). (G) Schematic representation of proposed mechanistic pathway. Values represent mean ± SEM. *p<0.05, **p<0.01, ***p<0.001 vs control mice by two-way ANOVA followed by the Tukey’s post hoc test or unpaired two-tailed student-t-test.
Sting Inhibitor H 151, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sting+inhibitor+h-151/H+151/pm40966083-301-13-17
Average 94 stars, based on 1 article reviews
sting inhibitor h 151 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
sting inhibitor h151  (Selleck Chemicals)
95
Selleck Chemicals sting inhibitor h151
(A) Representative immunoblots for <t>STING,</t> P-IκBα, IκBα, P-NF-κB p65, NF-κB p65, GATA3, P- STAT6, STAT6 and β-actin from CTRL and TKO CD4 + T cells following DMSO or <t>H151</t> (500 nM) incubation for 48 hours. (B) Protein quantitation and ratio of STING/β-actin, P-IKBα/IKBα, P-NF-kB P65/NF-kB P65, GATA3/β-actin and P-STAT6/STAT6 by densitometry analysis (n=6-7 per group). (C) IL-4, IL-5 and IL-13 cytokine release in activated CD4 + T cells treated with either DMSO or H151 (500nM) (n=6-7 per group). (D) Representative immunoblots for STING, P-IκBα, IκBα, P-NF-κB p65, NF-kB p65, GATA3 and β-actin from CTRL and TKO CD4 + T cells incubated with negative control (N.C.) or with STING siRNA. (E) Protein quantitation and ratio of STING/β-actin, P-IκBα/IκBα, P-NF-κB P65/NF-κB P65 and GATA3/β-actin by densitometry analysis (n=6 per group). (F) IL-4, IL-5 and IL-13 cytokine release in activated CD4 + T cells incubated with either N.C. or STING siRNA (n=9-18 per group). (G) Schematic representation of proposed mechanistic pathway. Values represent mean ± SEM. *p<0.05, **p<0.01, ***p<0.001 vs control mice by two-way ANOVA followed by the Tukey’s post hoc test or unpaired two-tailed student-t-test.
Sting Inhibitor H151, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sting+inhibitor+h-151/diABZI+STING+agonist/pmc12804755-230-9-12
Average 95 stars, based on 1 article reviews
sting inhibitor h151 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
mouse cxcl10/ip-10/crg-2 antibody  (Bio-Techne corporation)
99
Bio-Techne corporation mouse cxcl10/ip-10/crg-2 antibody
(A) Representative immunoblots for <t>STING,</t> P-IκBα, IκBα, P-NF-κB p65, NF-κB p65, GATA3, P- STAT6, STAT6 and β-actin from CTRL and TKO CD4 + T cells following DMSO or <t>H151</t> (500 nM) incubation for 48 hours. (B) Protein quantitation and ratio of STING/β-actin, P-IKBα/IKBα, P-NF-kB P65/NF-kB P65, GATA3/β-actin and P-STAT6/STAT6 by densitometry analysis (n=6-7 per group). (C) IL-4, IL-5 and IL-13 cytokine release in activated CD4 + T cells treated with either DMSO or H151 (500nM) (n=6-7 per group). (D) Representative immunoblots for STING, P-IκBα, IκBα, P-NF-κB p65, NF-kB p65, GATA3 and β-actin from CTRL and TKO CD4 + T cells incubated with negative control (N.C.) or with STING siRNA. (E) Protein quantitation and ratio of STING/β-actin, P-IκBα/IκBα, P-NF-κB P65/NF-κB P65 and GATA3/β-actin by densitometry analysis (n=6 per group). (F) IL-4, IL-5 and IL-13 cytokine release in activated CD4 + T cells incubated with either N.C. or STING siRNA (n=9-18 per group). (G) Schematic representation of proposed mechanistic pathway. Values represent mean ± SEM. *p<0.05, **p<0.01, ***p<0.001 vs control mice by two-way ANOVA followed by the Tukey’s post hoc test or unpaired two-tailed student-t-test.
Mouse Cxcl10/Ip 10/Crg 2 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sting+inhibitor+h-151/Mouse+CXCL10%2FIP-10%2FCRG-2+Antibody/bio-techne+corporation___mab466
Average 99 stars, based on 1 article reviews
mouse cxcl10/ip-10/crg-2 antibody - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
cd11b antibody / mac-1  (NSJ Bioreagents)
99
NSJ Bioreagents cd11b antibody / mac-1
(A) Representative immunoblots for <t>STING,</t> P-IκBα, IκBα, P-NF-κB p65, NF-κB p65, GATA3, P- STAT6, STAT6 and β-actin from CTRL and TKO CD4 + T cells following DMSO or <t>H151</t> (500 nM) incubation for 48 hours. (B) Protein quantitation and ratio of STING/β-actin, P-IKBα/IKBα, P-NF-kB P65/NF-kB P65, GATA3/β-actin and P-STAT6/STAT6 by densitometry analysis (n=6-7 per group). (C) IL-4, IL-5 and IL-13 cytokine release in activated CD4 + T cells treated with either DMSO or H151 (500nM) (n=6-7 per group). (D) Representative immunoblots for STING, P-IκBα, IκBα, P-NF-κB p65, NF-kB p65, GATA3 and β-actin from CTRL and TKO CD4 + T cells incubated with negative control (N.C.) or with STING siRNA. (E) Protein quantitation and ratio of STING/β-actin, P-IκBα/IκBα, P-NF-κB P65/NF-κB P65 and GATA3/β-actin by densitometry analysis (n=6 per group). (F) IL-4, IL-5 and IL-13 cytokine release in activated CD4 + T cells incubated with either N.C. or STING siRNA (n=9-18 per group). (G) Schematic representation of proposed mechanistic pathway. Values represent mean ± SEM. *p<0.05, **p<0.01, ***p<0.001 vs control mice by two-way ANOVA followed by the Tukey’s post hoc test or unpaired two-tailed student-t-test.
Cd11b Antibody / Mac 1, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sting+inhibitor+h-151/CD11b+Antibody+%2F+MAC-1/custom%40v2161%4035278833
Average 99 stars, based on 1 article reviews
cd11b antibody / mac-1 - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
g7131c  (Agilent Bio LC solutions)
95
Agilent Bio LC solutions g7131c
(A) Representative immunoblots for <t>STING,</t> P-IκBα, IκBα, P-NF-κB p65, NF-κB p65, GATA3, P- STAT6, STAT6 and β-actin from CTRL and TKO CD4 + T cells following DMSO or <t>H151</t> (500 nM) incubation for 48 hours. (B) Protein quantitation and ratio of STING/β-actin, P-IKBα/IKBα, P-NF-kB P65/NF-kB P65, GATA3/β-actin and P-STAT6/STAT6 by densitometry analysis (n=6-7 per group). (C) IL-4, IL-5 and IL-13 cytokine release in activated CD4 + T cells treated with either DMSO or H151 (500nM) (n=6-7 per group). (D) Representative immunoblots for STING, P-IκBα, IκBα, P-NF-κB p65, NF-kB p65, GATA3 and β-actin from CTRL and TKO CD4 + T cells incubated with negative control (N.C.) or with STING siRNA. (E) Protein quantitation and ratio of STING/β-actin, P-IκBα/IκBα, P-NF-κB P65/NF-κB P65 and GATA3/β-actin by densitometry analysis (n=6 per group). (F) IL-4, IL-5 and IL-13 cytokine release in activated CD4 + T cells incubated with either N.C. or STING siRNA (n=9-18 per group). (G) Schematic representation of proposed mechanistic pathway. Values represent mean ± SEM. *p<0.05, **p<0.01, ***p<0.001 vs control mice by two-way ANOVA followed by the Tukey’s post hoc test or unpaired two-tailed student-t-test.
G7131c, supplied by Agilent Bio LC solutions, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sting+inhibitor+h-151/g7131c/custom%40g7131c%4041534479
Average 95 stars, based on 1 article reviews
g7131c - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

Image Search Results


(A) Representative immunoblots for STING, P-IκBα, IκBα, P-NF-κB p65, NF-κB p65, GATA3, P- STAT6, STAT6 and β-actin from CTRL and TKO CD4 + T cells following DMSO or H151 (500 nM) incubation for 48 hours. (B) Protein quantitation and ratio of STING/β-actin, P-IKBα/IKBα, P-NF-kB P65/NF-kB P65, GATA3/β-actin and P-STAT6/STAT6 by densitometry analysis (n=6-7 per group). (C) IL-4, IL-5 and IL-13 cytokine release in activated CD4 + T cells treated with either DMSO or H151 (500nM) (n=6-7 per group). (D) Representative immunoblots for STING, P-IκBα, IκBα, P-NF-κB p65, NF-kB p65, GATA3 and β-actin from CTRL and TKO CD4 + T cells incubated with negative control (N.C.) or with STING siRNA. (E) Protein quantitation and ratio of STING/β-actin, P-IκBα/IκBα, P-NF-κB P65/NF-κB P65 and GATA3/β-actin by densitometry analysis (n=6 per group). (F) IL-4, IL-5 and IL-13 cytokine release in activated CD4 + T cells incubated with either N.C. or STING siRNA (n=9-18 per group). (G) Schematic representation of proposed mechanistic pathway. Values represent mean ± SEM. *p<0.05, **p<0.01, ***p<0.001 vs control mice by two-way ANOVA followed by the Tukey’s post hoc test or unpaired two-tailed student-t-test.

Journal: bioRxiv

Article Title: BLOC1S1 control of vacuolar organelle fidelity modulates T H 2 cell immunity and allergy susceptibility

doi: 10.1101/2024.03.21.586144

Figure Lengend Snippet: (A) Representative immunoblots for STING, P-IκBα, IκBα, P-NF-κB p65, NF-κB p65, GATA3, P- STAT6, STAT6 and β-actin from CTRL and TKO CD4 + T cells following DMSO or H151 (500 nM) incubation for 48 hours. (B) Protein quantitation and ratio of STING/β-actin, P-IKBα/IKBα, P-NF-kB P65/NF-kB P65, GATA3/β-actin and P-STAT6/STAT6 by densitometry analysis (n=6-7 per group). (C) IL-4, IL-5 and IL-13 cytokine release in activated CD4 + T cells treated with either DMSO or H151 (500nM) (n=6-7 per group). (D) Representative immunoblots for STING, P-IκBα, IκBα, P-NF-κB p65, NF-kB p65, GATA3 and β-actin from CTRL and TKO CD4 + T cells incubated with negative control (N.C.) or with STING siRNA. (E) Protein quantitation and ratio of STING/β-actin, P-IκBα/IκBα, P-NF-κB P65/NF-κB P65 and GATA3/β-actin by densitometry analysis (n=6 per group). (F) IL-4, IL-5 and IL-13 cytokine release in activated CD4 + T cells incubated with either N.C. or STING siRNA (n=9-18 per group). (G) Schematic representation of proposed mechanistic pathway. Values represent mean ± SEM. *p<0.05, **p<0.01, ***p<0.001 vs control mice by two-way ANOVA followed by the Tukey’s post hoc test or unpaired two-tailed student-t-test.

Article Snippet: The following inhibitors were added to the cells for 24 hours before harvesting: the NF-κB inhibitor JSH23 (2 μM, Tocris Bioscience), STING inhibitor H151 (5 μM, Tocris Bioscience), or Rapamycin (2 μM, Selleckchem).

Techniques: Western Blot, Incubation, Protein Quantitation, Negative Control, Control, Two Tailed Test